Aluko Atinuke, Enofe Ikponmwosa, Burch Jacob, Yam Julie, Khan Nazia
Michigan State University, Department of Internal Medicine, East Lansing, MI, USA.
Sparrow hospital, Lansing, MI, USA.
Case Reports Hepatol. 2020 Feb 17;2020:9368348. doi: 10.1155/2020/9368348. eCollection 2020.
Glycogenic hepatopathy (GH) is the accumulation of glycogen in the hepatocytes and represents a rare complication in patients with diabetes mellitus (DM), most commonly type 1 DM. We present a case of a 23-year-old woman with a medical history of poorly controlled type 1 DM and gastroesophageal reflux disease (GERD) who presented with progressively worsening right-sided abdominal pain. Diagnostic workup resulted in a liver biopsy with hepatocytes that stained heavily for glycogen with no evidence of fibrosis or steatohepatitis. A diagnosis of glycogenic hepatopathy was made, and an aggressive glucose control regimen was implemented leading to resolution of symptoms and improvement in AST, ALT, and ALP. In addition to presenting this rare case, we offer a review of literature and draw important distinctions between glycogenic hepatopathy and other differential diagnoses with the aim of assisting providers in the diagnostic workup and treatment of glycogenic hepatopathy.
糖原性肝病(GH)是糖原在肝细胞内蓄积,是糖尿病(DM)患者中一种罕见的并发症,最常见于1型糖尿病。我们报告一例23岁女性病例,她有1型糖尿病控制不佳及胃食管反流病(GERD)病史,出现进行性加重的右侧腹痛。诊断性检查包括肝脏活检,结果显示肝细胞糖原染色阳性,无纤维化或脂肪性肝炎证据。诊断为糖原性肝病,并实施积极的血糖控制方案,症状得以缓解,AST、ALT和ALP有所改善。除了报告这一罕见病例外,我们还对文献进行了综述,并明确了糖原性肝病与其他鉴别诊断之间的重要区别,旨在帮助医疗人员对糖原性肝病进行诊断性检查和治疗。